Related Experiment Video
Updated: Aug 14, 2026

Conjunctival Commensal Isolation and Identification in Mice
Published on: May 1, 2021
In vitro antimicrobial activity of Shiva-11 against ocular pathogens
L Gunshefski1, M J Mannis, J S Cullor
1Department of Ophthalmology, School of Medicine, University of California, Davis.
Abstract:
Cecropins are antimicrobial peptides (30-35 amino acids) isolated from the hemolymph of the cecropia moth. Previous studies have demonstrated their antimicrobial efficacy against a variety of pathogens, including both gram-positive and -negative bacteria, fungi, protozoa, and enveloped viruses. To assess their therapeutic potential against ocular pathogens, we analyzed the in vitro antimicrobial activity of a synthetic cecropin analog, Shiva-11, against virulent microbial strains (Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Candida albicans). Bacterial isolates were obtained from human cases of severe ulcerative keratitis. Shiva-11 was tested at varying concentrations in bacterial suspensions containing 1-2 x 10(6) CFU/ml at 37 degrees C. Samples were plated on nutrient agar and colonies counted after 24-48 h of incubation. Shiva-11 yielded > 3 log killing of all isolates after 60 min of exposure to this compound. The results of this study indicate that Shiva-11 possesses broad-spectrum in vitro antimicrobial activity against human clinical ocular pathogens.
Insights
A synthetic cecropin analog, Shiva-11, shows broad-spectrum antimicrobial activity against common ocular pathogens. This peptide demonstrates significant killing of bacteria and fungi, suggesting therapeutic potential for eye infections.
Area of Science:
- Microbiology
- Peptide Science
- Ophthalmology
Background:
- Cecropins are antimicrobial peptides from the cecropia moth with known efficacy against diverse pathogens.
- Ocular infections pose a significant threat, necessitating novel therapeutic agents.
Purpose of the Study:
- To evaluate the in vitro antimicrobial activity of the synthetic cecropin analog Shiva-11.
- To assess Shiva-11's potential against key human clinical ocular pathogens.
Main Methods:
- Shiva-11 was tested against Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Candida albicans.
- Antimicrobial activity was assessed by exposing bacterial suspensions to varying concentrations of Shiva-11 at 37°C.
- Colony counts were determined after 24-48 hours of incubation on nutrient agar.
Main Results:
- Shiva-11 demonstrated a greater than 3-log reduction in all tested isolates within 60 minutes.
- The compound exhibited broad-spectrum activity against gram-positive bacteria, gram-negative bacteria, and fungi.
Conclusions:
- The synthetic cecropin analog Shiva-11 possesses potent in vitro antimicrobial activity.
- Shiva-11 shows promise as a therapeutic agent for treating human clinical ocular infections.
Related Concept Videos
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Ophthalmic Drug Delivery Systems
Antimicrobial Effectiveness
Microbiome of the Eye

